Cited by 159Schizophrenia research and treatmentGlobal Cancer Incidence and ScreeningCancer, Stress, Anesthesia, and Immune Response

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.

Reduced cancer incidence among patients with schizophrenia

Open access

Barak, Yoram, Achiron, Anat, Mandel, Matilda, Mirecki, Ilona, Aizenberg, Dov·2005·Cancer

DOI 10.1002/cncr.21574

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The incidence of cancer in patients with schizophrenia has been conversely reported to be higher, lower, or similar to that in the general population. The effects of lifestyle factors such as excess smoking, exposure to neuroleptic medications, and genetic factors that may influence the incidence of cancer in this group are not clear. The current study was performed to evaluate the frequency of cancer in a large cohort of patients with schizophrenia and to determine the standardized incidence ratios (SIRs) of any malignancy in this group. METHODS: Data regarding the design, setting, and participants of the current study were analyzed from a cohort of 3226 patients with schizophrenia who were enrolled in the computerized health registry of the Abarbanel Mental Health Center between1993–2003. The mean age of the patients at the time of the diagnosis of cancer was 49 ± 14.7 years, with the majority of patients (61%) being male. All patients with schizophrenia records in the database were combined with the records of the Israeli National Cancer Registry to identify pathologically confirmed cancer comorbidity. The cancer incidence rates among patients with schizophrenia were compared with the expected incidence in an age‐matched and gender‐matched general population sample for the same time interval. RESULTS: Among 1247 female patients with schizophrenia, 22 (1.8%) developed breast cancer and 68 (5.5%) developed cancers of any type. Fifty‐two of the 1979 male schizophrenic patients (2.6%) developed cancer. The SIRs were 0.58 (95% confidence interval [95% CI], 0.48–0.69) with a P value of < 0.05 for all cancers in the cohort, and 0.60 (95% CI, 0.37–0.90) for female breast cancer. CONCLUSIONS: The results of the current study demonstrate a reduced risk of cancer in patients with schizophrenia. The mechanisms responsible for the lower risk need be investigated further. Cancer 2005. © 2005 American Cancer Society.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/cncr.21574

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The 1986 census of population and housing
Cornish, J. K. (1985) · Journal of the Australian Population Association · doi:10.1007/bf03041202 · Cited by 1,410
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Medical Comorbidity in Schizophrenia
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., & Lacro, J. P. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.413 · Cited by 617
Schizophrenia and smoking: an epidemiological survey in a state hospital
de León, J., Dadvand, M., Canuso, C. M., Odom-White, A., Stanilla, J. K., & Simpson, G. M. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.453 · Cited by 417
Incidence of Cancer Among Persons With Schizophrenia and Their Relatives
Lichtermann, D., Ekelund, J., Pukkala, E., Tanskanen, A., & Lönnqvist, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.573 · Cited by 292 · cited 7×
“Conversely, Lichtermann et al.1 reported on a higher overall cancer risk, with nearly half of the excess cases attributable to lung cancer, yet the incidence of breast cancer was unchanged.”
BackgroundResultInfluential
Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects
Halbreich, U. M., Kinon, B. J., Gilmore, J. A., & Kahn, L. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00112-9 · Cited by 248
Premature Deaths in Schizophrenia and Affective Disorders
Tsuang, M. T. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780220017001 · Cited by 198
Somatic Healthcare Utilization Among Adults With Serious Mental Illness Who Are Receiving Community Psychiatric Services
Dickerson, F., McNary, S. W., Brown, C. H., Kreyenbuhl, J. A., Goldberg, R. W., & Dixon, L. B. (2003) · Medical Care · doi:10.1097/01.mlr.0000053440.18761.f0 · Cited by 157
The occurence of cancer in first admitted schizophrenic patients
Mortensen, P. B. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90028-0 · Cited by 142
Mortality and causes of death in schizophrenic patients in Denmark
Mortensen, P. B., & Juel, K. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05466.x · Cited by 138

Flagged first, then by citations

Show all 26 references

1 of the 26 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

Dupont A, 1986, Psychiatric case registers in public health, 229
Central Bureau of Statistics of Israel, 2002, Census of Population and Housing, 2
Shalev AY, 1994, Structured clinical interview for axis I DSM‐IV patient edition
10.1016/S0920-9964(02)00430-9 · DOI

Sorted by citations

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,101
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633
Psychosis and autism as diametrical disorders of the social brain
Crespi, B. J., & Badcock, C. R. (2008) · Behavioral and Brain Sciences · doi:10.1017/s0140525x08004214 · Cited by 635
Impact of Stress on Cancer Metastasis
Moreno‐Smith, M., Lutgendorf, S. K., & Sood, A. K. (2010) · Future Oncology · doi:10.2217/fon.10.142 · Cited by 522
The High Prevalence of Poor Physical Health and Unhealthy Lifestyle Behaviours in Individuals with Severe Mental Illness
Scott, D. S., & Happell, B. (2011) · Issues in Mental Health Nursing · doi:10.3109/01612840.2011.569846 · Cited by 443
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 430
Inflammation and the two-hit hypothesis of schizophrenia
Feigenson, K. A., Kusnecov, A., & Silverstein, S. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.006 · Cited by 293
Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression
Callaghan, R. C., Veldhuizen, S., Jeysingh, T., Orlan, C., Graham, C., Kakouris, G., Remington, G., & Gatley, J. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.09.014 · Cited by 255
Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder: Nested Case-Control Study
Hippisley-Cox, J., Vinogradova, Y., Coupland, C., & Parker, C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.12.1368 · Cited by 214
Cancer incidence in patients with schizophrenia and their first‐degree relatives – a meta‐analysis
Catts, V. S., Catts, S. V., O’Toole, B. I., & Frost, A. D. J. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01163.x · Cited by 209
Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies
Catalá-López, F., Suárez‐Pinilla, M., Suárez‐Pinilla, P., Valderas, J. M., Gómez-Beneyto, M., Martı́nez, S., Balanzá‐Martínez, V., Climent, J., Valencia, A., McGrath, J. J., et al. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000356498 · Cited by 203
Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005
Capasso, R., Lineberry, T. W., Bostwick, J. M., Decker, P. A., & Sauver, J. L. S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.005 · Cited by 202
The incidence and relative risk factors for developing cancer among patients with schizophrenia: A nine-year follow-up study
Chou, F. H., Tsai, K., Su, C., & Lee, C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.02.018 · Cited by 149
Tobacco Use Among Individuals With Schizophrenia: What Role Has the Tobacco Industry Played?
Prochaska, J. J., Hall, S. M., & Bero, L. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm117 · Cited by 139
A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival
Chang, C., Hayes, R. D., Broadbent, M. T. M., Hotopf, M. H., Davies, E., Møller, H., & Stewart, R. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004295 · Cited by 139
Excess Cancer Mortality in Psychiatric Patients
Kisely, S., Sadek, J., MacKenzie, A., Lawrence, D., & Campbell, L. A. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805301107 · Cited by 128
Drug Repositioning in Glioblastoma: A Pathway Perspective
Tan, S. K., Jermakowicz, A. M., Mookhtiar, A. K., Nemeroff, C. B., Schürer, S. C., & Ayad, N. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00218 · Cited by 116
Cancer screening, prevention, and treatment in people with mental illness
Weinstein, L. C., Stefančić, A., Cunningham, A., Hurley, K. E., Cabassa, L. J., & Wender, R. C. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21334 · Cited by 112
Disparities in Breast and Cervical Cancer Screening in Women with Mental Illness
Aggarwal, A., Pandurangi, A. K., & Smith, W. R. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.006 · Cited by 109
Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis
Ranjan, A., Gupta, P., & Srivastava, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1233 · Cited by 105
Can Stopping Nerves, Stop Cancer?
Saloman, J. L., Albers, K. M., Rhim, A. D., & Davis, B. M. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.10.002 · Cited by 105
Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective
Weissenrieder, J., Neighbors, J. D., Mailman, R. B., & Hohl, R. J. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256818 · Cited by 112
Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review
Hert, M. A. F. D., Peuskens, J., Sabbe, T., Mitchell, A. J., Stubbs, B., Neven, P., Wildiers, H. P. M. W., & Detraux, J. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12459 · Cited by 99
The incidence rate of cancer in patients with schizophrenia: A meta-analysis of cohort studies
Li, H., Li, J., Yu, X., Zheng, H., Sun, X., Lü, Y., Zhang, Y., Li, C., & Bi, X. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.08.065 · Cited by 96
Association of Schizophrenia With the Risk of Breast Cancer Incidence
Zhuo, C., & Triplett, P. T. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4748 · Cited by 97
Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower?
Kisely, S. R., Forsyth, S. J., & Lawrence, D. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415577979 · Cited by 96
Cancer Incidence in Patients With Schizophrenia or Bipolar Disorder: A Nationwide Population-Based Study in Taiwan, 1997-2009
Lin, G., Chen, Y.-J., Kuo, D.-J., Jaiteh, L. E. S., Wu, Y., Lo, T.-S., & Li, Y.-H. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr162 · Cited by 91
Repurposing psychiatric drugs as anti-cancer agents
Huang, J., Zhao, D., Liu, Z., & Liu, F. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.058 · Cited by 89
Antipsychotic drugs: Pro-cancer or anti-cancer? A systematic review
Fond, G. B., Macgregor, A., Attal, J., Larue, A., Brittner, M., Ducasse, D., & Capdevielle, D. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.03.026 · Cited by 89
Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment
Barr, A. M., Procyshyn, R. M., Hui, P., Johnson, J. L., & Honer, W. G. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.027 · Cited by 85
DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond
Markkanen, E., Meyer, U., & Dianov, G. L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060856 · Cited by 84
Mortality among People with Severe Mental Disorders Who Reach Old Age: A Longitudinal Study of a Community-Representative Sample of 37892 Men
Almeida, O. P., Hankey, G. J., Yeap, B. B., Golledge, J., Norman, P. E., & Flicker, L. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111882 · Cited by 82
Review: Cancer and schizophrenia: is there a paradox?
Hodgson, R. E., Wildgust, H. J., & Bushe, C. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385489 · Cited by 86
Schizophrenia and breast cancer incidence
Bushe, C., Bradley, A. J., Wildgust, H. J., & Hodgson, R. E. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.012 · Cited by 77
Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?
Grigore, A. D., Ben‐Jacob, E., & Farach‐Carson, M. C. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00037 · Cited by 78
Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis
Ranjan, A., & Srivastava, S. (2016) · Scientific Reports · doi:10.1038/srep26165 · Cited by 66
Schizophrenia: The Epidemiological Horizon
Jablensky, A. V., Kirkbride, J. B., & Jones, P. B. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch10 · Cited by 66
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
Lee, J., Nam, D., & Lee, J. (2016) · Oncology Letters · doi:10.3892/ol.2016.4074 · Cited by 63
Unmet needs in the management of schizophrenia
Torres‐González, F., Ibáñez-Casas, I., Saldivia, S., Ballester, D., Pamela Grandón, F., Moreno‐Küstner, B., Xavier, M., & Gómez-Beneyto, M. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s41063 · Cited by 71
Cancer risk among parents and siblings of patients with schizophrenia
Levav, I., Lipshitz, I., Novikov, I., Pugachova, I., Kohn, R., Barchana, M., Ponizovsky, A. M., & Werner, H. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.106.024943 · Cited by 59
Drug rechanneling: A novel paradigm for cancer treatment
Kaushik, I., Ramachandran, S., Prasad, S., & Srivastava, S. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.011 · Cited by 60
The origins and evolution of genetic disease risk in modern humans
Crespi, B. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05707.x · Cited by 57
Schizophrenia and Cancer: In 2010 Do We Understand the Connection?
Bushe, C., & Hodgson, R. E. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005501203 · Cited by 55
Autism and cancer risk
Crespi, B. J. (2011) · Autism Research · doi:10.1002/aur.208 · Cited by 53
Association between schizophrenia and genetic variation in DCC: a case–control study
Grant, A., Fathalli, F., Rouleau, G., Joober, R., & Flores, C. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.02.023 · Cited by 53
Epidemiology and comorbidity of severe mental illnesses in the community: findings from a computerized mental health registry in a large Israeli health organization
Kodesh, A., Goldshtein, I., Gelkopf, M., Goren, I., Chodick, G., & Shalev, V. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-012-0478-9 · Cited by 53
Differences in cancer stage, treatment and in-hospital mortality between patients with and without schizophrenia: retrospective matched-pair cohort study
Ishikawa, H., Yasunaga, H., Matsui, H., Fushimi, K., & Kawakami, N. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156265 · Cited by 53
Cancer in patients with schizophrenia: W hat is the next step?
Chou, F. H., Tsai, K., Wu, H., & Shen, S. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12420 · Cited by 54
The overall and sex- and age-group specific incidence rates of cancer in people with schizophrenia: a population-based cohort study
Pettersson, D. R., Gissler, M., Hällgren, J., Ösby, U., Westman, J., & Bobo, W. V. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579602000044x · Cited by 52
Personalized Treatment of Glioblastoma: Current State and Future Perspective
Rončević, A., Koruga, N., Koruga, A. S., Rončević, R., Rotim, T., Šimundić, T., Kretić, D., Perić, M., Turk, T., & Štimac, D. (2023) · Biomedicines · doi:10.3390/biomedicines11061579 · Cited by 55
Antipsychotic dopamine receptor antagonists, cancer, and cancer stem cells
Roney, M. S. I., & Park, S. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1017-3 · Cited by 50
Clozapine Induces Autophagic Cell Death in Non-Small Cell Lung Cancer Cells
Yin, Y., Lin, C.-C., Chen, T., Chen, J., Tsai, H., Wang, C.-Y., & Chen, S. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369751 · Cited by 47
Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter
Asada, M., Ebihara, S., Numachi, Y., Okazaki, T., Yamanda, S., Ikeda, K., Yasuda, H., Sora, I., & Arai, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23562 · Cited by 47
D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells
Mori, T., Kabashima, K., Fukamachi, S., Kuroda, E., Sakabe, J., Kobayashi, M., Nakajima, S., Nakano, K., Tanaka, Y., Matsushita, S., et al. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.03.008 · Cited by 47
Physical Illness and Schizophrenia
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543951 · Cited by 45
Haloperidol Induced Cell Cycle Arrest and Apoptosis in Glioblastoma Cells
Papadopoulos, F., Isihou, R., Alexiou, G. Α., Tsalios, T., Vartholomatos, E., Markopoulos, G. S., Sioka, C., Tsekeris, P. G., Kyritsis, A. P., & Galani, V. (2020) · Biomedicines · doi:10.3390/biomedicines8120595 · Cited by 42
Inverse association between cancer risks and age in schizophrenic patients: A 12‐year nationwide cohort study
Lin, C., Lane, H., Chen, T., Wu, Y., Wu, C., & Wu, V. Y. (2013) · Cancer Science · doi:10.1111/cas.12094 · Cited by 40
Lung cancer incidence in patients with schizophrenia: meta-analysis
Zhuo, C., Zhuang, H., Gao, X., & Triplett, P. T. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.23 · Cited by 40
Prostate cancer and schizophrenia
Torrey, E. F. (2006) · Urology · doi:10.1016/j.urology.2006.08.1061 · Cited by 40
Schizoaffective Disorder
Kantrowitz, J. T., & Citrome, L. (2011) · CNS Drugs · doi:10.2165/11587630-000000000-00000 · Cited by 39
Surprising Anticancer Activities of Psychiatric Medications: Old Drugs Offer New Hope for Patients With Brain Cancer
Zhuo, C., Xun, Z., Hou, W., Ji, F., Lin, X., Tian, H., Zheng, W., Chen, M., Liu, C., Wang, W., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01262 · Cited by 39
Breast cancer in women suffering from serious mental illness
Barak, Y., Levy, T., Achiron, A., & Aizenberg, D. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.03.017 · Cited by 38
Self-citation
Cancer incidence in people with affective disorder: nationwide cohort study in Taiwan, 1997–2010
Hung, Y., Yang, S.-Y., Huang, M., Lung, F., Lin, S., Chen, K., Kuo, C., & Chen, Y. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.144741 · Cited by 36
Cancer incidence and stage at diagnosis among people with psychotic disorders: Systematic review and meta-analysis
Wootten, J. C., Wiener, J. C., Blanchette, P., & Anderson, K. K. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102233 · Cited by 36
Prospects for repurposing CNS drugs for cancer treatment
Abdelaleem, M., Ezzat, H., Osama, M., Megahed, A. A., Alaa, W., Gaber, A. I., Shafei, A., & Refaat, A. (2019) · Oncology Reviews · doi:10.4081/oncol.2019.411 · Cited by 34
PHLPP1 splice variants differentially regulate AKT and PKCα signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus
Jackson, T. C., Verrier, J. D., Semple‐Rowland, S. L., Kumar, A., & Foster, T. C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06984.x · Cited by 34
Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy
Xing, Y., Wei, X., Wang, M., Liu, Y., Sui, Z., Wang, X., Zhang, Y., Fei, Y.-H., Jiang, Y., Chen, L., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.043 · Cited by 33
New drugs for brain tumors? Insights from chemical probing of neural stem cells
Diamandis, P., Sacher, A. G., Tyers, M., & Dirks, P. B. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.10.034 · Cited by 31
Analysis of schizophrenia and hepatocellular carcinoma genetic network with corresponding modularity and pathways: novel insights to the immune system
Huang, K.-C., Yang, K.-C., Lin, H., Tsao, T. T.-H., Lee, W., Lee, S., & Kao, C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-s5-s10 · Cited by 30
Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis
Xue, Q., Liu, Z., Feng, Z., Xu, Y. X., Zuo, W., Wang, Q., Gao, T., Zeng, J., Hu, X., Jia, F., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109598 · Cited by 32
Comprehensive functional annotation of susceptibility SNPs prioritized 10 genes for schizophrenia
Niu, H., Yang, P., Chen, H., Hao, R.-H., Dong, S., Yao, S., Chen, X., Yan, H., Zhang, Y., Chen, Y., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0398-5 · Cited by 30
Cancer risk in patients with bipolar disorder and unaffected siblings of such patients: A nationwide population‐based study
Chen, M., Tsai, S., Su, T., Li, C., Lin, W., Cheng, C., Chen, T., & Bai, Y. (2021) · International Journal of Cancer · doi:10.1002/ijc.33914 · Cited by 31
Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V
Rai, S., Tanaka, H., Suzuki, M., Espinoza, J. L., Kumode, T., Tanimura, A., Yokota, T., Oritani, K., Watanabe, T., Kanakura, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17666-8 · Cited by 29
Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma
Ni, B., Yin, Y., Li, Z., Wang, J., Wang, X., & Wang, K. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01082-1 · Cited by 31
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
Rebelo, R., Polónia, B. R. G., Santos, L. L., Vasconcelos, M. H., & Xavier, C. P. R. (2021) · Pharmaceuticals · doi:10.3390/ph14030280 · Cited by 30
Cancer mortality among psychiatric patients treated in a community-based system of care: a 25-year case register study
Perini, G., Grigoletti, L., Hanife, B., Biggeri, A., Tansella, M., & Amaddeo, F. (2013) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-013-0765-0 · Cited by 26
Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
de Bartolomeis, A., Ciccarelli, M., Simone, G. D., Mazza, B., Barone, A., & Vellucci, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065945 · Cited by 29
Meta-analysis of the Correlation Between Schizophrenia and Breast Cancer
Zhang, X., Zhao, S., Feijiang, Y., Bo, C., Shifeng, Y., & Qihui, C. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.10.012 · Cited by 24
Convolutional neural network in proteomics and metabolomics for determination of comorbidity between cancer and schizophrenia
Kopylov, A. T., Petrovskiy, D. V., Stepanov, A. A., Rudnev, V. R., Malsagova, K. A., Butkova, T. V., Zakharova, N. V., Kostyuk, G. P., Kulikova, L. I., Enikeev, D. V., et al. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103890 · Cited by 23
Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
Persico, M., Abbruzzese, C., Matteoni, S., Matarrese, P., Campana, A. M., Villani, V., Pace, A., & Paggi, M. G. (2022) · Cells · doi:10.3390/cells11020263 · Cited by 21
Polymorphisms of XRCC4 are involved in reduced colorectal cancer risk in Chinese schizophrenia patients
Wang, Y., Wang, L., Li, X., Liu, B., Zhao, Q., Chen, P., Wang, T., Li, T., Ji, J., Yang, F., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-523 · Cited by 22
Trifluoperazine and Its Analog Suppressed the Tumorigenicity of Non-Small Cell Lung Cancer Cell; Applicability of Antipsychotic Drugs to Lung Cancer Treatment
Jeong, J. Y., Park, H., Yoo, H., Kim, E., Jeon, B., Lee, J. D., Kang, D., Lee, C. J., Paek, S. H., Roh, E. J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051046 · Cited by 20
Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN
Jacob, J. R., Palanichamy, K., & Chakravarti, A. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06779-3 · Cited by 22
Psychiatric Disorder as a Risk Factor for Cancer
Whitley, E., Batty, G. D., Mulheran, P. A., Galé, C. R., Osborn, D., Tynelius, P., & Rasmussen, F. E. (2012) · Epidemiology · doi:10.1097/ede.0b013e3182547094 · Cited by 20
Cancer in parents of persons with schizophrenia: Is there a genetic protection?
Gal, G., Goral, A., Murad, H., Gross, R., Pugachova, I., Barchana, M., Kohn, R., & Levav, I. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.04.018 · Cited by 21
Association Between the Maryland Medicaid Behavioral Health Home Program and Cancer Screening in People With Serious Mental Illness
Murphy, K. A., Daumit, G. L., Bandara, S. N., Stone, E. M., Kennedy‐Hendricks, A., Stuart, E. A., Pollack, C. E., & McGinty, E. E. (2020) · Psychiatric Services · doi:10.1176/appi.ps.201900299 · Cited by 20
Mammography stages of change in middle-aged women with schizophrenia: An exploratory analysis
Lindamer, L. A., Wear, E., & Sadler, G. R. (2006) · BMC Psychiatry · doi:10.1186/1471-244x-6-49 · Cited by 19
The risk for cancer among patients with schizoaffective disorders
Levav, I., Kohn, R., Barchana, M., Lipshitz, I., Pugachova, I., Weizman, A., & Grinshpoon, A. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.010 · Cited by 18
Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis
Srivastava, S., Zahra, F. T., Gupta, N., Tullar, P., Srivastava, S. K., & Mikelis, C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030755 · Cited by 18
Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates
Antoszczak, M., Markowska, A., Markowska, J., & Huczyński, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200907141452 · Cited by 18
Schizophrenia, Cancer and Obstetric Complications in an Evolutionary Perspective-An Empirically Based Hypothesis
Preti, A., & Wilson, D. R. (2011) · Psychiatry Investigation · doi:10.4306/pi.2011.8.2.77 · Cited by 18
Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder
Hippisley‐Cox, J., Vinogradova, Y., Coupland, C. A. C., & Parker, C. (2015) · Cited by 19
Identification of pimavanserin tartrate as a potent Ca2+-calcineurin-NFAT pathway inhibitor for glioblastoma therapy
Liu, Z., Liu, X., Fan, R., Jia, Y.-P., Zhang, Q., Gao, X.-Q., Wang, Y., Yang, M., Ji, L.-Z., Zhou, Y., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00724-2 · Cited by 17
Activation of IL-8 and its participation in cancer in schizophrenia patients: new evidence for the autoimmune hypothesis of schizophrenia
Xu, L., Qi, X., Zhu, C., & Wan, L. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s188210 · Cited by 17
Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs
Jóźwiak-Bębenista, M., Jasińska-Stroschein, M., & Kowalczyk, E. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.05.005 · Cited by 16
Tumor suppression and improvement in immune systems by specific activation of dopamine D1-receptor-expressing neurons in the nucleus accumbens
Sato, D., Hamada, Y., Narita, M., Mori, T., Tezuka, H., Suda, Y., Tanaka, K., Yoshida, S., Tamura, H., Yamanaka, A., et al. (2022) · Molecular Brain · doi:10.1186/s13041-022-00902-1 · Cited by 15
The Risk and The Course of Cancer Among People with Severe Mental Illness
Grassi, L. G., McFarland, D. C., & Riba, M. (2022) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/17450179-v17-e211208-2021-ht2-1910-8 · Cited by 15
miRNAs and their role in the correlation between schizophrenia and cancer
Rizos, E. N., Siafakas, N., Skourti, E., Papageorgiou, C., Tsoporis, J. N., Parker, T. H., Christodoulou, D. I., Spandidos, D. A., Katsantoni, E. Z., & Zoumpourlis, V. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5853 · Cited by 15
Evaluation of miRNA Expression Profiles in Schizophrenia Using Principal-Component Analysis-Based Unsupervised Feature Extraction Method
Pala, E., & Denkçeken, T. (2019) · Journal of Computational Biology · doi:10.1089/cmb.2019.0412 · Cited by 14

Authors: Barak, Y., Achiron, A., Mandel, M., Mirecki, I., & Aizenberg, D.
Affiliations: Tel Aviv University (IL)
Corresponding author: Barak, Yoram
ORCID: Barak, Yoram
Achiron, Anat
Venue: Cancer
Publisher: Wiley
Published: 2005-11-15
Volume: 104
Issue: 12
Pages: 2817-2821
ISSN: 0008-543X (ISSN-L)
1097-0142
DOI: 10.1002/cncr.21574
OpenAlex: W1535192849
Cited by: 159
References: 26
Citations by year: 2026: 1 · 2025: 2 · 2024: 3 · 2023: 11 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 10 · 2017: 4 · 2016: 9 · 2015: 8 · 2014: 12 · 2013: 11 · 2012: 7
FWCI: 3.80
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
Keywords: schizophrenia, cancer incidence, breast cancer, standardized incidence ratio, cancer comorbidity, antipsychotic drugs, smoking, genetic factors, psychiatric patients
MeSH terms: Adult, Aged, Female, Humans, Israel, Male, Middle Aged, Neoplasms, Prognosis, Registries, Schizophrenia, Severity of Illness Index, Cohort Studies, Comorbidity, Incidence, Survival Rate, Confidence Intervals, Odds Ratio, Age Distribution, Sex Distribution, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reduced cancer incidence among patients with schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks